Evolent Health (NYSE:EVH) Given Buy Rating at Truist Financial
Truist Financial reiterated their buy rating on shares of Evolent Health (NYSE:EVH – Free Report) in a report issued on Tuesday, Benzinga reports. They currently have a $33.00 price target on the technology company’s stock. Other analysts also recently issued reports about the stock. Royal Bank of Canada reaffirmed an outperform rating and issued a […]
More Stories
World News in Brief: North Gaza under siege, aid to millions in Syria, tensions in Mozambique
The UN aid coordination office (OCHA) on Tuesday reported further attacks on displacement shelters in Gaza which have been ongoing...
Destra Multi-Alternative Fund (NYSE:DMA) Sees Large Increase in Short Interest
Destra Multi-Alternative Fund (NYSE:DMA – Get Free Report) was the recipient of a significant growth in short interest in the...
Bancroft Fund Ltd. (NYSEAMERICAN:BCV) Sees Large Growth in Short Interest
Bancroft Fund Ltd. (NYSEAMERICAN:BCV – Get Free Report) saw a significant increase in short interest in the month of December....
Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Update
Dominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the recipient of a large growth in short interest in the...
Global X Renewable Energy Producers ETF (NASDAQ:RNRG) Sees Significant Increase in Short Interest
Global X Renewable Energy Producers ETF (NASDAQ:RNRG – Get Free Report) saw a large growth in short interest during the...
Raytech Holding Ltd. (NASDAQ:RAY) Sees Significant Increase in Short Interest
Raytech Holding Ltd. (NASDAQ:RAY – Get Free Report) was the target of a large increase in short interest in December....